Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate Versus Delayed Chemotherapy for Asymptomatic Advanced Colorectal Cancer
NCT00002570Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Jul 1994
- Primary completion
- Nov 2000
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fluorouracil and folinic acid in colorectal cancer (CRC) (2 arms), sponsored by Canadian Cancer Trials Group. Primary endpoint: Overall Survival at 8 years. Started Jul 1994; status: completed.
02
Drugs
fluorouracilfolinic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00002570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002570.